Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Muscle Disorders

ng-nitroarginine methyl ester has been researched along with Muscle Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barron, FE; Burridge, PW; Churko, JM; Diecke, S; Gold, JD; Gu, M; He, C; Hu, S; Kooreman, NG; Lee, J; Mordwinkin, NM; Ong, SG; Wu, H; Wu, JC1
Cellek, S; Minhas, S; Muneer, A; Ralph, DJ1
Jeyarasasingam, G; Quik, M; Yeluashvili, M2
Babül, A; Sayan, H; Ugurlu, B1

Other Studies

5 other study(ies) available for ng-nitroarginine methyl ester and Muscle Disorders

ArticleYear
Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.
    European heart journal, 2015, Apr-01, Volume: 36, Issue:13

    Topics: Analysis of Variance; Animals; Apoptosis; Cell Differentiation; Diet, High-Fat; Endothelial Cells; Enzyme Inhibitors; Fibroblasts; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induced Pluripotent Stem Cells; Injections, Intramuscular; Ischemia; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Oxidative Stress; Pravastatin; Proto-Oncogene Proteins c-akt; Random Allocation; Reperfusion Injury; Signal Transduction

2015
The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism.
    BJU international, 2008, Volume: 102, Issue:8

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcysteine; Animals; Calcium; Digoxin; Glutathione; Male; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Muscular Diseases; NG-Nitroarginine Methyl Ester; Penis; Priapism; Rabbits

2008
Tacrine, a reversible acetylcholinesterase inhibitor, induces myopathy.
    Neuroreport, 2000, Apr-27, Volume: 11, Issue:6

    Topics: Animals; Cholinesterase Inhibitors; Diaphragm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Muscle, Skeletal; Muscular Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tacrine

2000
Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:1

    Topics: Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Muscles; Muscular Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Paraoxon; Rats; Rats, Sprague-Dawley; Time Factors

2000
Effects of nitric oxide donor and inhibitor on prostaglandin E2-like activity, malondialdehyde and reduced glutathione levels after skeletal muscle ischemia-reperfusion.
    Prostaglandins, leukotrienes, and essential fatty acids, 2001, Volume: 65, Issue:4

    Topics: Animals; Arginine; Dinoprostone; Enzyme Inhibitors; Glutathione; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Muscle, Skeletal; Muscular Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Rats; Rats, Wistar; Reperfusion Injury

2001